Amoxicillin + Clavulanic AcidThird Party Manufacturing in India

Amoxicillin + Clavulanic Acid works by combining a broad-spectrum penicillin antibiotic with a powerful beta-lactamase inhibitor to overcome bacterial resistance. The amoxicillin component binds to and inactivates penicillin-binding proteins located on the inner membrane of the bacterial cell wall. This binding blocks the cross-linking of peptidoglycan chains, which are essential for maintaining bacterial cell wall stability, leading to cell wall rupture and rapid bacterial death. However, many resistant bacteria produce beta-lactamase enzymes that degrade amoxicillin, rendering it useless. Clavulanic acid acts as a suicide inhibitor, structurally mimicking the penicillin molecule to bind irreversibly to the active sites of these beta-lactamase enzymes. This blockade shields amoxicillin from enzymatic degradation, restoring and extending its bactericidal spectrum against resistant bacterial strains.

Unlike standard penicillin monotherapy, this combination is highly effective against beta-lactamase-producing pathogens such as Haemophilus influenzae and Klebsiella species. The injectable form is particularly valuable in acute clinical settings where high serum concentration is required quickly.

Amoxicillin + Clavulanic Acid third party manufacturing in India is a major segment of our pharmaceutical production capabilities, providing high-quality sterile injectables for global distribution.

Therapeutic Uses

Amoxicillin + Clavulanic Acid injection is prescribed for the treatment of:

• Severe Respiratory Tract Infections: Used for acute bacterial sinusitis, tonsillitis, and severe community-acquired pneumonia where beta-lactamase resistance is suspected.
• Skin and Soft Tissue Infections: Treats severe cellulitis, animal bites, and post-operative wound infections.
• Bone and Joint Infections: Indicated for osteomyelitis and septic arthritis caused by susceptible organisms.
• Intra-Abdominal Infections: Effective against mixed aerobic and anaerobic infections within the peritoneal cavity.

Why Choose a Leading Amoxicillin + Clavulanic Acid Manufacturer

Sourcing from a WHO-GMP certified facility in India ensures that the sterile injectable formulation meets the highest international quality standards. The manufacture of sterile injectables requires strict cleanroom classification, environmental monitoring, and high-speed filling lines to prevent contamination and maintain stability. By partnering with an experienced WHO-GMP certified manufacturing associate, distributors get access to export-ready packaging, comprehensive regulatory dossier support, and reliable batch-to-batch consistency.

We offer comprehensive contract manufacturing services for this molecule, and you can view our full range of products in our manufacturing listing. Please contact our team to discuss your specific requirements.

This makes Amoxicillin + Clavulanic Acid one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.